publication venue for
- Rituximab therapy for adult refractory systemic lupus erythematosus with neurological and/or psychiatric presentations: a PRISMA-compliant meta-analysis. 20. 2024
- Changes in Market Share of Biologic and Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs for Treatment of Rheumatoid Arthritis: Results from the Ontario Best-Practice Research Initiative Database. 17:349-359. 2021
- Quantitative Sensory Testing Protocols to Evaluate Central and Peripheral Sensitization in Knee OA: A Protocol for a Scoping Review. 17:76-80. 2021
- Cardiovascular and Pulmonary Manifestations of Systemic Lupus Erythematosus. 13:206-218. 2017